English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Aims  Guidelines recommend testing HbA 1c  every 3–6 months in people with diabetes. In the United Kingdom ( UK ), primary care clinics are financially incentivized to monitor HbA 1c  at least annually and report proportions of patients meeting targets on 31 March. We explored the hypothesis that this reporting deadline may be associated with over‐frequent or delayed HbA 1c  testing.    Methods  This analysis used HbA 1c  results from 100 000 people with diabetes during 2005–2014 in the Clinical Practice Research Datalink  UK  primary care database. Logistic regression was used to explore whether the four months prior to the deadline for quality reporting (December to March) or individual's previous HbA 1c  were aligned with retesting HbA 1c  within 60 days or > 1 year from the previous test, and identify other factors associated with the timing of HbA 1c  testing.    Results  Retesting HbA 1c  within 60 days or > 1 year was more common in December to March compared with other months of the year (odds ratio 1.06, 95% confidence interval 1.04–1.08 for retesting within 60 days). Those with higher HbA 1c  were more likely to have a repeat test within 60 days and less likely to have a repeat test > 1 year from the previous test.    Conclusions  We have found that retesting HbA 1c  within 60 days and > 1 year from the previous test was more common in December to March compared with the other months of the year. This work suggests that both practice‐centred administrative factors and patient‐centred considerations may be influencing diabetes care in the  UK .

Timings for HbA 1c testing in people with diabetes are associated with incentive payments: an analysis of UK primary care data